Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Clinical trial NCT06572618 · RECRUITING
Trial details
- NCT number
- NCT06572618
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-22
- Primary completion
- 2027-01-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.